Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06893627Not ApplicableNot Yet Recruiting

Body Project SMIL: Prevention of Eating Disorders Among Young Women With Psychiatric Illness With the Body Project

Role: collaborator

NCT06312410Not ApplicableRecruiting

The VIA Family 2.0 - a Family Based Intervention for Families with Parental Mental Illness

Role: collaborator

NCT02885792Not ApplicableUnknown

Coronary Artery Disease in Patients Suffering From Schizophrenia

Role: lead

NCT00885690Not ApplicableTerminated

Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)

Role: collaborator

NCT01282307Not ApplicableCompleted

Improving Insight in Patients Diagnosed With Schizophrenia

Role: collaborator

NCT01138618Completed

Hematological Clozapine Monitoring With a Point-of-care Device (CHEMPAQ)

Role: collaborator

All 6 trials loaded